Postprandial serum C-peptide to plasma glucose ratio as a predictor of subsequent insulin treatment in patients with type 2 diabetes.

No abstract is available for this paper.

• Publication year

  2011

• Venue

  Endocrine journal

• Publication date

  2011-05-13

• Fields of study

  Medicine

• Identifiers
  DOI 10.1507/ENDOCRJ.K10E-399PMID 21415555
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Body mass index, fasting plasma glucose levels, and C-peptide levels as predictors of the future insulin use in Japanese type 2 diabetic patients.

  2010cited by this paper
• Report of the Committee on the Classification and Diagnostic Criteria of Diabetes Mellitus

  2010cited by this paper
• Beta cell dysfunction and its clinical significance in gestational diabetes.

  2010cited by this paper
• Modification of the CKD epidemiology collaboration (CKD-EPI) equation for Japanese: accuracy and use for population estimates.

  2010cited by this paper
• Beneficial Effects of Insulin on Glycemic Control and β-Cell Function in Newly Diagnosed Type 2 Diabetes With Severe Hyperglycemia After Short-Term Intensive Insulin Therapy

  2009cited by this paper
• Revised equations for estimated GFR from serum creatinine in Japan.

  2009cited by this paper
• From the Triumvirate to the Ominous Octet: A New Paradigm for the Treatment of Type 2 Diabetes Mellitus

  2009cited by this paper
• Effects of insulin vs. glibenclamide in recently diagnosed patients with type 2 diabetes: a 4‐year follow‐up

  2008cited by this paper
• Effect of intensive insulin therapy on beta-cell function and glycaemic control in patients with newly diagnosed type 2 diabetes: a multicentre randomised parallel-group trial.

  2008cited by this paper
• Beneficial Effects of Insulin on Glycemic Control and β-Cell Function in Newly Diagnosed Type 2 Diabetes With Severe Hyperglycemia After Short-Term Intensive Insulin Therapy

  2008cited by this paper
• Analysis of factors influencing pancreatic beta-cell function in Japanese patients with type 2 diabetes: association with body mass index and duration of diabetic exposure.

  2008cited by this paper
• The rise and fall of insulin secretion in type 1 diabetes mellitus

  2006cited by this paper
• The incretin system: glucagon-like peptide-1 receptor agonists and dipeptidyl peptidase-4 inhibitors in type 2 diabetes.

  2006cited by this paper
• The natural course of beta-cell function in nondiabetic and diabetic individuals: the Insulin Resistance Atherosclerosis Study.

  2006cited by this paper
• C-peptide and autoimmune markers in diabetes.

  2003cited by this paper
• UKPDS 26: sulphonylurea failure in non‐insulin‐dependent diabetic patients over six years

  1998cited by this paper

• Clinical Risk Score is Superior to Fasting C‐peptide–Based β‐Cell Function Markers in Predicting Insulin Requirement in Individuals With Type 2 Diabetes

  2026cites this paper
• Effect of Beta-Cell Function on Glucose Variability When Switching From Insulin Degludec Plus a Dipeptidyl Peptidase-4 Inhibitor to Insulin Degludec/Liraglutide: Preliminary Results From a Pilot Study

  2025cites this paper
• C-peptide Index under Non-fasting Conditions can Predict the Likelihood of Future Insulin Therapy in Outpatients with Type 2 Diabetes Mellitus not Receiving Insulin at Baseline.

  2025cites this paper
• Utility of the random C-peptide and random C-peptide index at diagnosis as a predictor of disease type and long-term insulin secretory capacity in children with diabetes mellitus

  2025cites this paper
• Engineering pore-enriched and pre-vascularized volumetric constructs for enhanced blood glucose regulation in type 1 diabetes therapy

  2024cites this paper
• High glutamic acid decarboxylase antibody titers may be associated with a decline in β-cell function over time and future insulin deficiency in latent autoimmune diabetes in adults.

  2024cites this paper
• Clinical Utility of Serum C-Peptide Concentration for Hospitalized Patients with Hyperglycemia

  2024cites this paper
• Association of xanthine oxidoreductase inhibitor use with insulin secretory capacity in patients with type 2 diabetes

  2024cites this paper
• The effect of different times of day for exercise on blood glucose fluctuations.

  2024cites this paper
• C‐peptide index at 2 h post‐meal is a useful predictor of endogenous insulin secretory capacity and withdrawal from insulin therapy in subjects with type 2 diabetes

  2024cites this paper
• Retrospective Study of IDegLira, a New Fixed-Ratio Combination, in Japanese Patients With Type 2 Diabetes Mellitus: Analysis of Background Factors Affecting Effectiveness After 6 Months of Treatment

  2023cites this paper
• Alogliptin: a DPP-4 inhibitor modulating adipose tissue insulin resistance and atherogenic lipid

  2023cites this paper
• Combined Hypophysitis and Type 1 Diabetes Mellitus Related to Immune Checkpoint Inhibitors

  2023cites this paper
• The average 30-minute post-prandial C-peptide predicted diabetic retinopathy progress: a retro-prospective study

  2023cites this paper
• Food Polyphenols and Type II Diabetes Mellitus: Pharmacology and Mechanisms

  2023cites this paper
• Short‐term recovery of insulin secretion in response to a meal is associated with future glycemic control in type 2 diabetes patients

  2023influential citation
• A prospective guide for clinical implementation of selected OGTT-derived surrogate indices for the evaluation of β-cell function and insulin sensitivity in patients with transfusion-dependent β-thalassaemia

  2023influential citation
• Metyrosine-associated endocrinological changes in pheochromocytoma and paraganglioma

  2023cites this paper
• Glucagon Test Is a Useful Predictor of Withdrawal From Insulin Therapy in Subjects With Type 2 Diabetes Mellitus

  2022cites this paper
• Exploring a Suitable Marker of Glycemic Response to Dulaglutide in Patients with Type 2 Diabetes: A Retrospective Study

  2022cites this paper
• Leveraging the future of diagnosis and management of diabetes: From old indexes to new technologies

  2022cites this paper
• Therapeutic Potential of Quercetin in the Management of Type-2 Diabetes Mellitus

  2022cites this paper
• Perioperative C‐peptide index is associated with the status of diabetes management after pancreatectomy

  2022cites this paper
• Clinical Characteristics Associated with the Development of Diabetic Ketoacidosis in Patients with Type 2 Diabetes

  2022cites this paper
• Hyperglycemia in acute COVID-19 is characterized by insulin resistance and adipose tissue infectivity by SARS-CoV-2

  2021influential citation
• The relationship between postprandial C peptide-glucose ratio, beta-cell function and treatment success in type 2 diabetes mellitus

  2021cites this paper
• Hyperglycemia in acute COVID-19 is characterized by insulin resistance and adipose tissue infectivity by SARS-CoV-2

  2021cites this paper
• Hyperglycemia in Acute COVID-19 is Characterized by Adipose Tissue Dysfunction and Insulin Resistance

  2021cites this paper
• Arbutin alleviates diabetic symptoms by attenuating oxidative stress in a mouse model of type 1 diabetes

  2021cites this paper
• Beta-cell failure in type 2 diabetes: mechanisms, markers, and clinical implications

  2020cites this paper
• Prognostic factors and a new preliminary scoring system for remission of type 2 diabetes mellitus after laparoscopic sleeve gastrectomy

  2020cites this paper
• Pancreatic fat accumulation evaluated by multidetector computed tomography in patients with type 2 diabetes

  2020cites this paper
• Evaluation of the relationship between non-alcoholic fatty liver disease and serum c-peptide, c-peptide to glucose and c-peptide to HbA1C ratio in obese children

  2020cites this paper
• Clinical Utility of the Meal Tolerance Test in the Care of Patients with Type 2 Diabetes Mellitus

  2020cites this paper
• The Relationship Between C-Peptide Index and Proteinuria in Patients with Type 2 Diabetes Mellitus

  2020cites this paper
• Comparison of New and Old Body Shape Indices to Estimate Body Fat in Obese and Morbid Obese Turkish Females

  2020cites this paper
• The Relationship Between C-Peptide Index and Proteinuria in Patients with Type 2 Diabetes Mellitus Tip 2 Diabetes Mellitus Hastalarında C-Peptid İndeks ile

  2020cites this paper
• Changing the Concept of Type 2 Diabetes: Beta Cell Workload Hypothesis Revisited

  2019cites this paper
• Dynamic derangement in amino acid profile during and after a stroke-like episode in adult-onset mitochondrial disease: a case report

  2019cites this paper
• Differential role of insulin resistance and β-cell function in the development of prediabetes and diabetes in middle-aged and elderly Chinese population

  2019cites this paper
• Circulating anti‐glutamic acid decarboxylase‐65 antibody titers are positively associated with the capacity of insulin secretion in acute‐onset type 1 diabetes with short duration in a Japanese population

  2019cites this paper
• Significance of peripheral mononuclear cells producing interferon-γ in response to insulin B:9-23-related peptides in subtypes of type 1 diabetes.

  2019cites this paper
• Sepsis uncouples serum C-peptide and insulin levels in critically ill patients with type 2 diabetes mellitus.

  2019cites this paper
• OGTT 2-hour serum C-peptide index as a predictor of post-transplant diabetes mellitus in kidney transplant recipients.

  2019cites this paper
• Family history of diabetes in both parents is strongly associated with impaired residual β‐cell function in Japanese type 2 diabetes patients

  2019cites this paper
• Anti-Diabetic Effect of Cotreatment with Quercetin and Resveratrol in Streptozotocin-Induced Diabetic Rats

  2018cites this paper
• The Postprandial-to-Fasting Serum C-Peptide Ratio is a Predictor of Response to Basal Insulin-Supported Oral Antidiabetic Drug(s) Therapy: A Retrospective Analysis

  2018cites this paper
• Increase in hepatic and decrease in peripheral insulin clearance characterize abnormal temporal patterns of serum insulin in diabetic subjects

  2018cites this paper
• Towards a personalized assessment of pancreatic function in diabetes

  2017cites this paper
• The effects of intermittent use of the SGLT-2 inhibitor, dapagliflozin, in overweight patients with type 2 diabetes in Japan: a randomized, crossover, controlled clinical trial

  2017cites this paper
• The effect of insulin administration on c-peptide in critically ill patients with type 2 diabetes

  2017cites this paper
• OGTT 1h serum C-peptide to plasma glucose concentration ratio is more related to beta cell function and diabetes mellitus.

  2017influential citation
• OGTT 1h serum C-peptide to plasma glucose concentration ratio is more related to beta cell function and diabetes mellitus

  2017cites this paper
• Evaluation of metabolic parameters and body composition in Japanese patients with type 2 diabetes mellitus who were administered tofogliflozin for 48 weeks

  2017cites this paper
• Features of pregnancy with gestational diabetes mellitus and prediction of diabetic fetopathy

  2017influential citation
• Bidirectional changes of hepatic and peripheral insulin clearance characterize abnormal temporal patterns of serum insulin concentration in diabetic subjects

  2017cites this paper
• Postprandial C-Peptide to Glucose Ratio as a Marker of β Cell Function: Implication for the Management of Type 2 Diabetes

  2016influential citation
• Long‐Term Follow‐Up of the Edmonton Protocol of Islet Transplantation in the United States

  2016cites this paper
• Insulin Initiation in Type 2 Diabetes – Why, When and How?

  2016cites this paper
• Current management of Alström syndrome and recent advances in treatment

  2016cites this paper
• Effects of Obesity and Diabetes on α- and β-Cell Mass in Surgically Resected Human Pancreas

  2016cites this paper
• Efficacy and safety of teneligliptin in addition to insulin therapy in type 2 diabetes mellitus patients on hemodialysis evaluated by continuous glucose monitoring.

  2016cites this paper
• Clinical features of childhood diabetes mellitus focusing on latent autoimmune diabetes

  2016cites this paper
• A reliable serum C-peptide index for the selection of an insulin regimen to achieve good glycemic control in obese patients with type 2 diabetes: an analysis from a short-term study with intensive insulin therapy

  2016cites this paper
• Characteristics Predictive for a Successful Switch from Insulin Analogue Therapy to Oral Hypoglycemic Agents in Patients with Type 2 Diabetes

  2016cites this paper
• Efficacy and safety of liraglutide monotherapy compared with metformin in Japanese overweight/obese patients with type 2 diabetes.

  2015cites this paper
• Analyzing the Factors Contributing to Withdrawal from Insulin Therapy Following Additional Administration of Alogliptin: Retrospective Study after Removing Glucotoxicity with Insulin

  2015cites this paper
• Serum C-peptide to plasma glucose ratio may be associated with efficacy of vildagliptin in Japanese patients with type 2 diabetes mellitus

  2015cites this paper
• β-cell dysfunction: Its critical role in prevention and management of type 2 diabetes.

  2015cites this paper
• Retrospective analysis of safety and efficacy of liraglutide monotherapy and sulfonylurea-combination therapy in Japanese type 2 diabetes: Association of remaining β-cell function and achievement of HbA1c target one year after initiation.

  2015cites this paper
• C-peptide immunoreactivity index is associated with improvement of HbA1c: 2-Year follow-up of sitagliptin use in patients with type 2 diabetes.

  2015influential citation
• Modification of severe insulin resistant diabetes in response to lifestyle changes in Alström syndrome.

  2014cites this paper
• Postprandial C-peptide Index: The Best Marker of Beta Cell Function?

  2014cites this paper
• Importance of Beta Cell Function for the Treatment of Type 2 Diabetes

  2014cites this paper
• Liraglutide normalised glucose tolerance and the response of insulin to glucose in a non-obese patient with newly diagnosed type-2 diabetes mellitus

  2014cites this paper
• Both Glimepiride and High-Dose Metformin Are Important for Sustained Glucose Lowering in Japanese Type 2 Diabetes Patients on Glimepiride–Sitagliptin–Metformin Therapy: Subanalysis of a Single-Center, Open-Label, Randomized Study

  2014cites this paper
• Postprandial C‐peptide to glucose ratio as a predictor of β‐cell function and its usefulness for staged management of type 2 diabetes

  2014cites this paper
• Correlation of serum CPR to plasma glucose ratio with various indices of insulin secretion and diseases duration in type 2 diabetes.

  2013cites this paper
• The clinical utility of C-peptide measurement in the care of patients with diabetes

  2013cites this paper
• Factors associated with glycemic variability in Japanese patients with diabetes

  2013cites this paper
• Association between beta cell function and future glycemic control in patients with type 2 diabetes.

  2013cites this paper
• Glimepiride Strongly Enhances the Glucose-Lowering Effect in Triple Oral Antidiabetes Therapy with Sitagliptin and Metformin for Japanese Patients with Type 2 Diabetes Mellitus

  2013cites this paper
• Postprandial serum C‐peptide value is the optimal index to identify patients with non‐obese type 2 diabetes who require multiple daily insulin injection: Analysis of C‐peptide values before and after short‐term intensive insulin therapy

  2013cites this paper
• Secretory units of islets in transplantation index is a useful predictor of insulin requirement in Japanese type 2 diabetic patients

  2013cites this paper
• Postprandial serum C-peptide to plasma glucose ratio predicts future insulin therapy in Japanese patients with type 2 diabetes

  2013cites this paper
• Postprandial serum C-peptide to plasma glucose concentration ratio correlates with oral glucose tolerance test- and glucose clamp-based disposition indexes.

  2013cites this paper
• Retrospective analysis of safety and efficacy of insulin‐to‐liraglutide switch in Japanese type 2 diabetes: A caution against inappropriate use in patients with reduced β‐cell function

  2013cites this paper
• Short duration of diabetes and disuse of sulfonylurea have any association with insulin cessation of the patients with type 2 diabetes in a clinical setting in Japan (JDDM 30).

  2013cites this paper
• Effect of obesity on declining beta cell function after diagnosis of type 2 diabetes: a possible link suggested by cross-sectional analysis.

  2012cites this paper
• Effectiveness of the glucagon test in estimating islet function for liraglutide treatment in a lean diabetic patient with impaired insulin response to glucose

  2012cites this paper
• New Indices for Predicting Glycaemic Variability

  2012cites this paper
• Assessment of endogenous insulin secretion in insulin treated diabetes predicts postprandial glucose and treatment response to prandial insulin

  2012cites this paper
• Glycated albumin to glycated hemoglobin ratio reflects postprandial glucose excursion and relates to beta cell function in both type 1 and type 2 diabetes

  2011cites this paper